PNMR for Post-COVID Syndrome

This trial explores a new treatment option for individuals dealing with Long COVID, a condition where symptoms persist or emerge months after the initial infection. Participants will receive either a new treatment called Paragon Novel Metabolic Regulator (PNMR) along with standard care or just standard care for six weeks. The researchers aim to determine if PNMR can manage Long COVID symptoms more effectively than standard care alone. Individuals with a confirmed COVID-19 diagnosis who continue to experience symptoms three months after infection might be suitable candidates. As a Phase 2 trial, this research measures the treatment's effectiveness in an initial, smaller group, offering a chance to contribute to important findings.

Yes, you will need to stop taking any over-the-counter supplements, vitamins, or natural products, as well as any medications that could affect fatigue and cognitive function during the study.

Earlier studies indicate that patients using Paragon Novel Metabolic Regulator (PNMR) have generally tolerated the treatment well, with few reports of side effects. Some individuals have experienced gas with a sulfur-like smell, signaling the body's adjustment to the treatment. Rarely, patients have reported unpleasant dreams, which may suggest a need for a lower dosage. This trial is in a phase that evaluates both safety and effectiveness, and earlier research suggested that PNMR is safe. However, as the treatment remains under investigation, researchers continue to learn about its safety for everyone.¹²³⁴⁵

The Paragon Novel Metabolic Regulator (PNMR) is unique because it targets post-COVID syndrome by focusing on the body's metabolic processes, specifically replenishing depleted sulfur protein nutrient stores essential for energy production and healing. Unlike standard treatments that typically manage symptoms with medications like corticosteroids or breathing exercises, PNMR potentially accelerates recovery by adjusting dosage based on individual healing signals, such as sulfur-smelling flatulence, which indicates the body's need for the active ingredient is decreasing. Researchers are excited about this treatment because it offers a personalized approach, allowing patients to tailor their dosage based on their body's signals, which could lead to more efficient and effective recovery from long COVID symptoms.

Research has shown that conditions like Long COVID link to changes in how the body uses energy and manages inflammation. Studies have found that these conditions cause noticeable shifts in these processes. In this trial, one group of participants will receive the Paragon Novel Metabolic Regulator (PNMR) along with dietary and lifestyle recommendations and standard care. Early results suggest that addressing these issues can improve symptoms for people with Long COVID, making PNMR a promising option for managing the condition.¹⁶⁷⁸⁹